Skip to content
Search

Latest Stories

PSNC urge pharmacy contractor to follow procedures for unplanned temporary closures

The Pharmaceutical Services Negotiating Committee (PSNC) has urged the pharmacy contractors to follow appropriate procedures for unplanned temporary closures due to current workforce pressure, to avoid a breach of terms of service.

“If the temporary closure is not for reasons beyond the contractor’s control, this may be a breach of the terms of service,” said PSNC.


The committee also informed that in some areas, NHS England regional teams may ask contractors to complete a new notification form for any temporary closures that request more information than the standard form, for example, on the mitigating actions taken by the contractor.

It added: “Completion of these forms is voluntary but may help to show NHS England that the closure was for reasons beyond the contractor’s control, or that the overall circumstances of the closure, including time closed and steps taken to ensure patient and public needs are met, indicate that there is no public interest in taking any regulatory/performance action (such as a breach notice) against the contractor.”

The procedures – as well as closing the premises and restricting entry/access – include the following:

  1. Notifying NHS England as soon as practical: There is an unplanned temporary suspension of services notification form which contractors should complete to notify NHS England of the temporary closure and the reasons for it.
  2. Updating the Directory of Services (DoS) and NHS website entries: Using NHS Profile Manager, contractors must update their DoS and the NHS website entries to ensure that they provide accurate information of the pharmacy’s opening hours to patients, the public, and other relevant NHS service providers.
  3. Trying to re-open the pharmacy: Contractors must use all reasonable endeavours to re-open and provide NHS pharmacy services as soon as practicable.
  4. Making alternative arrangements for the provision of NHS pharmacy services: Contractors must, where practicable, make alternative arrangements with one or more pharmacies in the area, for the ongoing provision of NHS pharmacy services.

Alternative arrangements for the ongoing provision of NHS pharmacy services are likely to include:

  1. Clinical: Identifying any urgent prescriptions which are awaiting dispensing, collection or delivery, such as those for antibiotics or analgesics, and making arrangements for the ongoing supply of medicines prescribed by installment prescriptions or supplied in monitored dosage systems. It is important that staff do as much as they can before they leave the premises to ensure patients are able to access their prescriptions.
  2. Information: Displaying clear notices advising patients and the public of the closure, including any arrangements for accessing their medicines and the estimated time when the pharmacy will re-open, and providing relevant information to those with, for example, urgent prescriptions.
  3. GPs: Informing local GP practices of the situation and any arrangements made with local pharmacies while the pharmacy is closed.

The committee is working with NHS England and the Department of Health and Social Care, as indicated in the CPCF Years 4 and 5 letter to contractors, to consider what can be done to relieve the current pressures contractors are facing.

More For You

Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less
Three pharmacists named in NIHR’s latest cohort of senior investigators

L-R: Professor David Alldred; Professor Rachel Elliott and Professor Ian Maidment.

Three pharmacists appointed as NIHR senior investigators

The National Institute for Health and Care Research (NIHR) has announced its latest cohort of senior investigators, including three distinguished pharmacists.

David Alldred, professor of medicines use and safety at the University of Leeds; Rachel Elliott, professor of health economics at the University of Manchester; and Ian Maidment, professor in clinical pharmacy at Aston University, have been named in the list of 39 new appointments, alongside 19 reappointed senior investigators.

Keep ReadingShow less
Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less